Homocysteine levels and echocardiographic findings in obstructive sleep apnea syndrome

Respiration

Volumn 79, Issue 1, 2009, Pages 38-45

  Sariman, Nesrin ^a   Levent, Ender ^a   Aksungar, Fehime Benli ^a   Soylu, Akin Cem ^a   Bektaş, Osman ^a  

^a MALTEPE UNIVERSITY   (Turkey)

Author keywords

C reactive protein; Echocardiography; Homocysteine; Obstructive sleep apnea syndrome

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; CYANOCOBALAMIN; HOMOCYSTEINE; TRIACYLGLYCEROL;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HUMAN; LUNG FUNCTION; MALE; OXYGEN SATURATION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; DISEASE PROGRESSION; FEMALE; HEART DISEASES; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; SLEEP APNEA, OBSTRUCTIVE;

EID: 73349101849     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000210429     Document Type: Article

References (22)

1. Young T, Peppard E, Gottlieb DJ: Epidemiology of obstructive sleep apnea. A population health perspective. Am J Respir Crit Care Med 2002; 165: 1217-1239.
2. Quan SF, Gersh BJ: Cardiovascular consequences of sleep-disordered breathing: past, present and future. Circulation 2004; 109: 951-957.
3. Lavie L, Perelman A, Lavie P: Plasma homocysteine levels in obstructive sleep apnea: Association with cardiovascular morbidity. Chest 2001; 120: 900-908.
4. Kokturk O, Ulukavak Ciftci T, Mollarecep E, Ciftci B: Serum homocysteine levels and cardiovascular morbidity in obstructive sleep apnea syndrome. Respir Med 2006; 100: 536-541.
5. Rechtschaffen A, Kales A: A manual of standardized terminology, techniques and scoring system for sleep stages in human subjects. Los Angeles, UCLA Brain Information Service, 1968.
6. Svatikova A, Wolk R, Magera MJ, Shamsuzzaman AS, Phillips BG, Somers VK: Plasma homocysteine in obstructive sleep apnoea. Eur Heart J 2004; 25: 1325-1329. (Pubitemid 38998509)
7. Ryan S, Nolan MG, Hannigan E, Cunningham S, Taylor C, McNicholas WT: Cardiovascular risk markers in obstructive sleep apnea syndrome and correlation with obesity. Thorax 2007; 62: 509-514.
8. Ridker PM: C-reactive protein and the prediction of cardiovascular events among those at intermediate risk. Moving an inflammatory hypothesis towards consensus. J Am Coll Cardiol 2007; 49: 2129-2138.
9. Mansfield D, Naughton MT: Obstructive sleep apnoea, congestive heart failure and cardiovascular disease. Heart Lung Circ 2005; 14S:S2-S7.
10. Krumdieck CL, Prince CW: Mechanisms of homocysteine toxicity on connective tissues: implications for the morbidity of aging. J Nutr 2000; 130: 365S-368S.
11. Selhub J: Homocysteine metabolism. Annu Rev Nutr 1999; 19: 217-246.
12. Can M, Acikgöz S, Mungan G, Bayraktaroglu T, Kocak E, Guven B, Demirtas S: Serum cardiovascular risk factors in obstructive sleep apnea. Chest 2006; 129: 233-237.
13. Kokturk O, Ulukavak Ciftci T, Mollarecep E, Ciftci B: Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome. Int Heart J 2005; 46: 801-809.
14. Wolk R, Shamsuzzaman ASM, Somers VK: Obesity, sleep apnea, and hypertension. Hypertension 2003; 42: 1067-1074.
15. Boudjeltia KZ, Meerhaeghe AV, Doumit S, Guillaume M, Cauche P, Brohee D: Sleep apnoea-hypopnoea index is an independent predictor of high sensitivity C-reactive protein elevation. Respiration 2006; 73: 243-246.
16. Romero-Corral A, Somers VK, Pellikka PA, Olson EJ, Bailey KR, Korinek J, Orban M, Sierra-Johnson J, Kato M, Amin RS, Lopez-Jimenez F: Decreased right and left ventricular myocardial performance in obstructive sleep apnea. Chest 2007; 132: 1863-1870.
17. Otto ME, Belohlavek M, Romero-Corral A, Gami AS, Gilman G, Svatikova A, Amin RS, Lopez-Jimenez F, Khandheria BK, Somers VK: Comparison of cardiac structural and functional changes in obese otherwise healthy adults with versus without obstructive sleep apnea. Am J Cardiol 2007; 99: 1298-1302.
18. Cloward TV, Walker JM, Farney RJ, Anderson JL: Left ventricular hypertrophy is a common echocardiographic abnormality in severe obstructive sleep apnea and reverses with nasal continuous positive airway pressure. Chest 2003; 124: 594-601.
19. Dursunoǧlu N, Dursunoǧlu D, Kiliç M: Impact of obstructive sleep apnea on right ventricular global function: sleep apnea and myocardial performance index. Respiration 2005; 72: 278-284.
20. Yavuz Z, Ursavas A, Ege E, Ilcol Ozarda Y, Karadag M, Uzaslan E, Gozu RO: Homocysteine levels in patients with obstructive sleep apnea syndrome (in Turkish). Tuberk Toraks 2008; 56: 37-42.
21. Ozkan Y, Firat H, Simsek B, Torun M, Akaydin SY: Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS). Sleep Breath 2008; 12: 149-154.
22. Lavie L: Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep Med Rev 2003; 7: 35-51.